State Street Corp Halozyme Therapeutics, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 6,053,007 shares of HALO stock, worth $350 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,053,007
Previous 7,184,636
15.75%
Holding current value
$350 Million
Previous $343 Million
12.44%
% of portfolio
0.02%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding HALO
# of Institutions
589Shares Held
123MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$742 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$225 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$212 Million5.31% of portfolio
-
Alliancebernstein L.P. New York, NY3.22MShares$186 Million0.08% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.05B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...